Literature DB >> 8334194

Diagnosis of invasive mycoses in severely immunosuppressed patients.

R Rüchel1.   

Abstract

In compromised patients, invasive mycoses are being observed at an increasing frequency and with a broadening spectrum of causative fungi. The rapid and definitive diagnosis of such opportunistic mycoses requires the synoptical consideration of predisposing clinical conditions, of culture isolates, and of the results of nonculture techniques. At present, the latter comprise the monitoring of specific antibodies and of fungal antigens, and the microscopical examination of suspected biopsies. The validity of the individual techniques (e.g., the monitoring of antibodies or antigens) varies with individual mycoses. Alternative methods for monitoring fungal metabolites or nucleic acids are still in the developmental stage. Particularly the amplification of DNA by the polymerase chain reaction (PCR) has a high diagnostic potential. However, at present, it is uncertain whether PCR allows the necessary distinction between colonization and truly invasive infection, and whether PCR can be simplified sufficiently to allow the continuous surveillance of high-risk patients.

Entities:  

Mesh:

Year:  1993        PMID: 8334194     DOI: 10.1007/bf01709659

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  77 in total

1.  Aspergillus antigen latex test for diagnosis of invasive aspergillosis.

Authors:  F Knight; D W Mackenzie
Journal:  Lancet       Date:  1992-01-18       Impact factor: 79.321

2.  Nonvalue of antigen detection immunoassays for diagnosis of candidemia.

Authors:  P Phillips; A Dowd; P Jewesson; G Radigan; M G Tweeddale; A Clarke; I Geere; M Kelly
Journal:  J Clin Microbiol       Date:  1990-10       Impact factor: 5.948

3.  Candida antigen latex test for detection of invasive candidiasis in immunocompromised patients.

Authors:  M J Ness; W P Vaughan; G L Woods
Journal:  J Infect Dis       Date:  1989-03       Impact factor: 5.226

4.  Identification of certain false-positive results in the Cand-Tec test for candidal antigen.

Authors:  R Rüchel
Journal:  Mycoses       Date:  1989-12       Impact factor: 4.377

Review 5.  Antigenicity of Aspergillus species.

Authors:  V M Hearn
Journal:  J Med Vet Mycol       Date:  1992

6.  Value of detection of antibodies to Candida albicans germ tube in the diagnosis of systemic candidosis.

Authors:  G Quindós; J Pontón; R Cisterna; D W Mackenzie
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-03       Impact factor: 3.267

7.  Predictive value of surveillance cultures for systemic infection due to Candida species.

Authors:  M Pfaller; I Cabezudo; F Koontz; M Bale; R Gingrich
Journal:  Eur J Clin Microbiol       Date:  1987-12       Impact factor: 3.267

Review 8.  Current concepts in cryptococcosis.

Authors:  T F Patterson; V T Andriole
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-05       Impact factor: 3.267

Review 9.  Aspergillosis.

Authors:  G P Bodey; S Vartivarian
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-05       Impact factor: 3.267

10.  Prospective study on humoral immune response induced by fungal infection in patients with hematologic malignancies.

Authors:  I Kostiala; E Elonen; P Ylipaavalniemi; A A Kostiala
Journal:  Infection       Date:  1986 Nov-Dec       Impact factor: 3.553

View more
  5 in total

1.  [Serological tests for diagnosing fungal infections].

Authors:  Cornelia Lass-Flörl
Journal:  Wien Med Wochenschr       Date:  2007

Review 2.  Molecular and nonmolecular diagnostic methods for invasive fungal infections.

Authors:  Marios Arvanitis; Theodora Anagnostou; Beth Burgwyn Fuchs; Angela M Caliendo; Eleftherios Mylonakis
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

Review 3.  [Preventive antimycotic therapy of neutropenic and immunosuppressed patients].

Authors:  M Ruhnke; J Beyer
Journal:  Med Klin (Munich)       Date:  1997-01-15

4.  Aerosol amphotericin B inhalations for prevention of invasive pulmonary aspergillosis in neutropenic cancer patients.

Authors:  G F Behre; S Schwartz; K Lenz; W D Ludwig; H Wandt; E Schilling; V Heinemann; H Link; A Trittin; O Boenisch
Journal:  Ann Hematol       Date:  1995-12       Impact factor: 3.673

5.  Preparation and evaluation of inhalable itraconazole chitosan based polymeric micelles.

Authors:  Esmaeil Moazeni; Kambiz Gilani; Abdolhossein Rouholamini Najafabadi; Mohamad Reza Rouini; Nasir Mohajel; Mohsen Amini; Mohammad Ali Barghi
Journal:  Daru       Date:  2012-12-03       Impact factor: 3.117

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.